Answers are grounded in this paper and cite their sources.
This study reports the efficient synthesis of three tetrasaccharide derivatives of Group B Streptococcus (GBS) serotype VIII capsular polysaccharide with alternative glycan sequences and spacer chains through a convergent chemical glycosylation manner or a one-pot three-enzyme assembly protocol. Using bifunctional glutarate ester as the linker, these synthesized oligosaccharides were efficiently conjugated with recombinant ScpA193 protein, generating the resultant oligosaccharide-ScpA193 conjugates with desirable carbohydrate loading. ELISA analysis of the antisera obtained from mice inoculated with the synthetic glycoconjugates showed the elicitation of strong oligosaccharide-specific immunoglobulin G (IgG) antibodies, suggesting the potential of the synthesized oligosaccharides for use in the development of GBS vaccines.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: